REPLIGEN CORP - COMMON STOCK (RGEN)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,095,854
Total 13F shares
58,123,283
Share change
+1,026,823
Total reported value
$10,446,984,164
Put/Call ratio
46%
Price per share
$179.80
Number of holders
463
Value change
+$202,954,749
Number of buys
209
Number of sells
202

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2023

As of 31 Dec 2023, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 463 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,123,283 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, MACQUARIE GROUP LTD, BROWN CAPITAL MANAGEMENT LLC, Artisan Partners Limited Partnership, SANDS CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp. This page lists 463 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.